| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |